跳至主要内容
临床试验/ACTRN12617001399381
ACTRN12617001399381已完成2 期

Intranasal Fentanyl versus Placebo for treatment of episodic breathlessness in hospice patients with advanced non-malignant terminal diseases, a randomized double blind crossover feasibility study

Medical Director, Dr Ian Gwynne Robson0 个研究点目标入组 20 人开始时间: 2017年10月4日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • The study population is composed of enrolled hospice patients with the following eligibility criteria:
  • Age, 18 and above
  • Primary diagnosis of non-malignant disease
  • Symptom of episodic dyspnoea on a daily basis at least once per day in the previous week
  • already on rescue opioid for episodic dypsnea

排除标准

  • Diagnosis of malignancy
  • Non English speaking
  • Unable to give informed consent
  • confirmed or suspected pregnancy
  • history of current history of depression

研究者

发起方
Medical Director, Dr Ian Gwynne Robson

相似试验